Market Place
Sourcing Support
Vanda gets $466M takeout bid from Cycle Pharma
06 Jun 2024 //
FIERCE PHARMA
Future Pak Increases Vanda Bid With CVRs, $7.25-$7.75 Per Share
07 May 2024 //
BUSINESSWIRE
Vanda Fanapt Receives FDA Approval for the Acute Treatment of Bipolar I Disorder
02 Apr 2024 //
PR NEWSWIRE
Vanda Pharma announces the publication of Efficacy and Safety of Iloperidone
17 Jan 2024 //
PR NEWSWIRE
Fanapt Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study
19 Dec 2022 //
PRNEWSWIRE
Vanda Pharmaceuticals Wins Key U.S. Supreme Court Patent Ruling on Fanapt®
13 Jan 2020 //
PR NEWSWIRE
Ten medicines recommended for approval, including two orphan
11 Nov 2017 //
EMA
Vanda Receives Negative Opinion for Mkt Authorization from the EMAon Fanaptum™
10 Nov 2017 //
PR NEWSWIRE
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
22 Jul 2017 //
RAPS
Vanda Pharma settles Fanapt patent litigation with Apotex
09 Dec 2016 //
PHARMABIZ
Vanda Pharmaceuticals Settles Fanapt® Patent Litigation with Apotex
07 Dec 2016 //
PR NEWSWIRE
Inventia`s Generic Iloperidone Receives Approval In US
28 Nov 2016 //
FDA
Vanda Pharmaceuticals Settles Fanapt Patent Litigation with Taro
25 Oct 2016 //
PR NEWSWIRE
USPTO Dismisses Petition for Inter Partes Review of Fanapt® Patent
31 Aug 2016 //
PR NEWSWIRE
Fake smiles star in Otsuka and Lundbeck`s DTC push for Rexulti in depression
10 Mar 2016 //
FIERCE PHARMA MARKETING
Allergan and Richter`s antipsychotic gets FDA OK but faces stiff competition
19 Sep 2015 //
FIERCE PHARMA
Vanda Announces Favorable Markman Ruling in Fanapt® Patent Infringement Litigation
10 Sep 2015 //
PR NEWS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.